Literature DB >> 26378285

Successful Treatment of Peritoneal Dialysis Catheter-Related Polymicrobial Peritonitis Involving Clostridium difficile.

Sheena Bharti1, Prashant Malhotra2, Stefan Juretschko3.   

Abstract

Clostridium difficile is one of the most common nosocomial pathogens and the cause of pseudomembranous colitis in cases of prior antimicrobial exposure. Extraintestinal manifestations of C. difficile are uncommon and rarely reported. We report the first successfully treated case of catheter-related C. difficile peritonitis in a patient undergoing peritoneal dialysis.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26378285      PMCID: PMC4652108          DOI: 10.1128/JCM.02021-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

Review 1.  Recurrent extraintestinal clostridium difficile infection.

Authors:  Roger Bedimo; Jeffrey Weinstein
Journal:  Am J Med       Date:  2003-06-15       Impact factor: 4.965

2.  Isolation of toxigenic Clostridium difficile from dialysate fluid in a fatal case of chronic ambulatory peritoneal dialysis-related peritonitis.

Authors:  M C Laroche; M J Alfa; G K Harding
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

Review 3.  Extracolonic manifestations of Clostridium difficile infections. Presentation of 2 cases and review of the literature.

Authors:  A Jacobs; K Barnard; R Fishel; J D Gradon
Journal:  Medicine (Baltimore)       Date:  2001-03       Impact factor: 1.889

4.  Peritoneal dialysis-related peritonitis triggered by Clostridium difficile-associated colitis.

Authors:  T Arikan; A Unal; I Kocyigit; A Yurci; O Oymak
Journal:  Perit Dial Int       Date:  2014 Jan-Feb       Impact factor: 1.756

Review 5.  Clostridium difficile in habitats other than the human gastro-intestinal tract.

Authors:  P N Levett
Journal:  J Infect       Date:  1986-05       Impact factor: 6.072

Review 6.  Evidence-based medicine: An update on treatments for peritoneal dialysis-related peritonitis.

Authors:  Pasqual Barretti; João Vitor Pereira Doles; Douglas Gonçalves Pinotti; Regina Paolucci El Dib
Journal:  World J Nephrol       Date:  2015-05-06

Review 7.  Treatment for peritoneal dialysis-associated peritonitis.

Authors:  Angela E Ballinger; Suetonia C Palmer; Kathryn J Wiggins; Jonathan C Craig; David W Johnson; Nicholas B Cross; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2014-04-26

8.  Risk of peritonitis and technique failure by CAPD connection technique: a national study.

Authors:  F K Port; P J Held; K D Nolph; M N Turenne; R A Wolfe
Journal:  Kidney Int       Date:  1992-10       Impact factor: 10.612

9.  Extraintestinal Clostridium difficile infections: a single-center experience.

Authors:  Arjun Gupta; Robin Patel; Larry M Baddour; Darrell S Pardi; Sahil Khanna
Journal:  Mayo Clin Proc       Date:  2014-09-20       Impact factor: 7.616

10.  Pathogenicity of Clostridium species with other bacteria in mixed infections.

Authors:  I Brook; R I Walker
Journal:  J Infect       Date:  1986-11       Impact factor: 6.072

View more
  3 in total

1.  Secondary bacterial peritonitis and pelvic abscess due to Clostridium difficile.

Authors:  Michelle Herberts; Bradley Hicks; Muhammad Rizwan Sohail; Anil Jagtiani
Journal:  BMJ Case Rep       Date:  2018-10-12

2.  Clostridium difficile Peritonitis: An Emerging Infection in Peritoneal Dialysis Patients.

Authors:  Saira Chaughtai; Bhavika Gandhi; Zeeshan Chaughtai; Dana Tarina; Mohammad A Hossain; Arif Asif
Journal:  Case Rep Med       Date:  2018-09-19

3.  Clostridioides difficile associated peritonitis in peritoneal dialysis patients - a case series based review of an under-recognized entity with therapeutic challenges.

Authors:  Kairav J Shah; Kartikeya Cherabuddi; Kalynn B Pressly; Kaitlyn L Wright; Ashutosh Shukla
Journal:  BMC Nephrol       Date:  2020-03-04       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.